EUVIMEDEUVIMED entdecken
Crossref

Diaryl pyrrolone fluorescent probing strategy for Mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: Application to dosage forms, human urine and plasma

Sayed M Derayea, Ahmed S Ahmed, Mohamed A Abdelshakour, Mohamed Oraby, Khalid M Badr El-Din

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024

DOI: 10.1016/j.saa.2024.124515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024. Verfasst von Sayed M Derayea und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt. Electronic address: sayed_derayea@yahoo.com. Hauptthemen laut MEDLINE: Ninhydrin, Spectrometry, Fluorescence, Limit of Detection, Acetanilides. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mirabegron (MRB) is a β3-adrenoceptor agonist used for managing overactive bladder syndrome. A cost-effective, environmentally friendly, and highly sensitive spectrofluorimetric method was suggested to serve the purpose of quantifying MRB in its pure state, pharmaceutical tablets, spiked human plasma and urine, and testing content uniformity. In the present study, ninhydrin and phenylacetaldehyde react with the amino group moiety of MRB in Teorell-Stenhagen buffer (pH 7.5) to generate a strongly fluorescent diaryl pyrrolone compound that emits fluorescence at a wavelength of 477 nm upon excitation at 385 nm. The obtained calibration curve showed a linear relationship with a high correlation coefficient (r = 0.9997) in the concentration range of 0.25 to 5.0 µg mL-1. Limits of detection (LOD) and quantitation (LOQ) were 0.082 and 0.248 µg mL-1 respectively. The procedure was verified in accordance with the ICH guidelines. The suggested approach could be utilized for the selective analysis of MRB in its pharmaceuticals, either containing a single drug or co-formulated with solifenacin succinate. The greenness of the suggested method was confirmed using different green analytical metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NinhydrinSpectrometry, FluorescenceLimit of DetectionAcetanilidesThiazolesHumansPyrrolesFluorescent DyesTabletsAcetaldehyde

Stichwörter der Autor:innen

Biological fluidsFluorescenceMirabegronNinhydrinPharmaceutical

Substanzen

NinhydrinmirabegronAcetanilidesThiazolesphenylacetaldehydePyrrolesFluorescent DyesTabletsAcetaldehyde

Autor:innen und Institutionen

  • Department of Analytical Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt. Electronic address: sayed_derayea@yahoo.com.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.

Zitieren

APA

Derayea, S. M., Ahmed, A. S., Abdelshakour, M. A., Oraby, M., & Badr El-Din, K. M. (2024). Diaryl pyrrolone fluorescent probing strategy for Mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: Application to dosage forms, human urine and plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2024.124515

Vancouver

Derayea SM, Ahmed AS, Abdelshakour MA, Oraby M, Badr El-Din KM. Diaryl pyrrolone fluorescent probing strategy for Mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: Application to dosage forms, human urine and plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2024. doi:10.1016/j.saa.2024.124515

BibTeX
@article{Derayea2024,
  author = {Derayea, Sayed M and Ahmed, Ahmed S and Abdelshakour, Mohamed A and Oraby, Mohamed and Badr El-Din, Khalid M},
  title = {Diaryl pyrrolone fluorescent probing strategy for Mirabegron determination through condensation with ninhydrin and phenylacetaldehyde: Application to dosage forms, human urine and plasma},
  journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
  year = {2024},
  doi = {10.1016/j.saa.2024.124515}
}
Kostenlos starten →